Hong Kong Stock Market | Fosun Pharma (02696.HK) surged more than 13% in early trading, H medicine received new indications in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.
According to the Securities Times app, Fuhong Hanlin (02696.HK) rose more than 13% in early trading, with a 13.33% increase as of press time, reaching 62.9 Hong Kong dollars, with a turnover of 34.7527 million Hong Kong dollars.
Latest
